lomerizine has been researched along with Cranial Nerve II Injuries in 8 studies
lomerizine: used to treat migraines
| Excerpt | Relevance | Reference |
|---|---|---|
| "Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immunoreactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred acutely." | 1.46 | Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma. ( Bartlett, CA; Chiha, W; Fitzgerald, M; Giacci, MK; Harvey, AR; Hodgetts, SI; O'Hare Doig, RL; Smith, NM; Yates, NJ, 2017) |
| "Partial optic nerve transection is an excellent model in which to unequivocally differentiate events occurring during secondary degeneration from those resulting from primary CNS injury." | 1.35 | Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. ( Bartlett, CA; Dunlop, SA; Evill, L; Fitzgerald, M; Harvey, AR; Rodger, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toomey, LM | 2 |
| Bartlett, CA | 7 |
| Gavriel, N | 1 |
| McGonigle, T | 1 |
| Majimbi, M | 2 |
| Gopalasingam, G | 2 |
| Rodger, J | 3 |
| Fitzgerald, M | 7 |
| O'Hare Doig, RL | 2 |
| Chiha, W | 1 |
| Giacci, MK | 1 |
| Yates, NJ | 1 |
| Smith, NM | 2 |
| Hodgetts, SI | 1 |
| Harvey, AR | 4 |
| Savigni, DL | 1 |
| Szymanski, CR | 1 |
| Lozić, I | 1 |
| Evill, L | 2 |
| Dunlop, SA | 3 |
| Payne, SC | 1 |
| Selt, M | 1 |
| Karim, Z | 1 |
| Sawada, A | 1 |
| Kawakami, H | 1 |
| Yamamoto, T | 1 |
| Taniguchi, T | 1 |
8 other studies available for lomerizine and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Drug Therapy, Combination; Female; Imidazoles; | 2019 |
Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Female; Imidazoles; Mac | 2017 |
Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Cell Adhesion Molecules, Neuronal; Dise | 2019 |
Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma.
Topics: Adenosine Triphosphate; Animals; Basic Helix-Loop-Helix Transcription Factors; Calcium Channel Block | 2013 |
Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine.
Topics: Animals; Axons; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Animal; Female; | 2009 |
Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine.
Topics: Animals; Calcium Channel Blockers; Carbocyanines; Caspase 3; Cell Count; Cell Death; Cell Survival; | 2009 |
Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine.
Topics: Animals; Calcium Channel Blockers; Cell Count; Cell Survival; Female; Immunohistochemistry; Macropha | 2010 |
A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.
Topics: Animals; Calcium Channel Blockers; Cell Count; Cell Death; Cell Survival; Male; Optic Nerve Injuries | 2006 |